Tokai Pharma (TKAI) – Analyst Ratings
-
BMO Capital Cuts Price Target as Tokai Pharma (TKAI) Stops ARMOR2 Trial Enrollment
-
BMO Capital Downgrades Tokai Pharmaceuticals (TKAI) to Market Perform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TKAI Stock Lookup